The device uses electromagnetic waves to target tumors and is available to patients for whom first- and second-line ...

Liver cancer rates have more than tripled in the U.S. since 1980 and continue to rise. More than 41,000 people will be ...

A MedUni Vienna study has identified a new approach to the drug treatment of metabolic liver diseases. In an experimental ...

Soliwoda-Doan was one of many Americans who had never even heard of H.B.V. There is no cure for hepatitis B, but it is ...

Gastroenterology Group of Rochester is part of GI Alliance - the premier physician-owned and led network of gastroenterology practices in the U.S. These physicians will work to provide the best ...

WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Wockhardt's Zaynich antibiotic enables successful liver transplant for US cancer patient, shares soar, Phase III study nears ...

Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at ...

Former Minnesota Vikings wide receiver Randy Moss says he is a "cancer survivor" after undergoing six-hour surgery to remove ...

These new insights into the role of CXCR4 in dendritic cells ... promising combination therapy and address the critical need for more effective treatments in liver cancer.

Pro Football Hall of Fame wide receiver Randy Moss says he is being treated for cancer and is recovering from major surgery.